Fantastic news......
Highlights: • Compumedics’ Neuroscan Orion LifeSpan™ MEG receives US Food and Drug Administration (FDA) approval in the United States, following installation at Barrow Neurological Institute in Arizona, USA
• Sites can now use the MEG for routine clinical examinations and bill for insurance reimbursement
• Significant milestone for the company’s MEG sales and marketing efforts
• Company continues to actively pursue forty identified MEG opportunities around the world, with four opportunities substantively advanced
Ann: MEG FDA Approval, page-3
Add CMP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.005(2.08%) |
Mkt cap ! $43.40M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $8.202K | 33.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 672 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 6505 | 1 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
24.0¢ |
Change
0.005 ( 2.04 %) |
||||
| Open | High | Low | Volume | ||
| 23.5¢ | 24.0¢ | 23.5¢ | 16958 | ||
| Last updated 12.54pm 03/06/2024 ? | |||||
| CMP (ASX) Chart |